Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine.

Authors:
Address: Hospital de Niños Ricardo Gutierrez, Epidemiología, Buenos Aires, Argentina.
Journal:


Publication:

abstract

OBJECTIVES:

In this open-label, non-randomized phase II study, the safety and Immunogenicity of a fully liquid diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b (DTPw-HepB-Hib) combination vaccine (Quinvaxem(®)) were assessed in infants who had or had not received a birth dose of hepatitis B (HepB) vaccine.

STUDY DESIGN:

Two groups of infants, 'HepB at birth' (n=110) and 'no HepB at birth' (n=108), were enrolled and received a primary vaccination course using a 2-4-6 months schedule.

RESULTS:

Seroprotection/seroconversion rates of >95% were achieved against all antigens included in the combination vaccine for both study groups. Although significantly higher anti-hepatitis B virus (p<0.001) and anti-tetanus (p=0.031) antibody titers were achieved in group 'HepB at birth' when compared with group 'no HepB at birth', the proportion of 'no HepB at birth' subjects achieving protective titers was non-inferior to the proportion of subjects in group 'HepB at birth'. The birth dose of HepB vaccine did not seem to influence the safety pattern of the DTPw-HepB-Hib combination vaccine.

CONCLUSIONS:

The present study demonstrated that the fully liquid DTPw-HepB-Hib vaccine was safe and immunogenic when administered using a 2-4-6 months immunization schedule, regardless of whether or not infants had received a dose of HepB vaccine at birth.

Copyright © 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.



Related Articles
Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants.
Hum Vaccin. 2006
Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants.
Kanra G, Kara A, Demiralp O, Contorni M, Hilbert AK, Spyr C, Viviani S. Hum Vaccin. 2006 Jul-Aug; 2(4):155-60. Epub 2006 Jul 21.
A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador.
Rev Panam Salud Publica. 2010
A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador.
Suárez E, Asturias EJ, Hilbert AK, Herzog C, Aeberhard U, Spyr C. Rev Panam Salud Publica. 2010 Feb; 27(2):117-24.
Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
Vaccine. 2003
Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
Arístegui J, Dal-Ré R, Díez-Delgado J, Marés J, Casanovas JM, García-Corbeira P, De Frutos E, Van Esso D, Verdaguer J, De la Flor J, et al. Vaccine. 2003 Sep 8; 21(25-26):3593-600.
Review Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
Cochrane Database Syst Rev. 2009
Review Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L. Cochrane Database Syst Rev. 2009 Jul 8; (3):CD005530. Epub 2009 Jul 8.
Review Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines.
Expert Opin Biol Ther. 2008
Review Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines.
Prymula R, Plisek S. Expert Opin Biol Ther. 2008 Apr; 8(4):503-13.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.